Title : Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis.

Pub. Date : 2021 Feb 17

PMID : 33597645






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator that is produced mainly from lysophosphatidylcholine (LPC) via autotaxin (ATX) and is known to induce NP via LPA1 receptor signaling in mice. lysophosphatidic acid ectonucleotide pyrophosphatase/phosphodiesterase 2 Mus musculus
2 Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator that is produced mainly from lysophosphatidylcholine (LPC) via autotaxin (ATX) and is known to induce NP via LPA1 receptor signaling in mice. lysophosphatidic acid ectonucleotide pyrophosphatase/phosphodiesterase 2 Mus musculus
3 Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator that is produced mainly from lysophosphatidylcholine (LPC) via autotaxin (ATX) and is known to induce NP via LPA1 receptor signaling in mice. lysophosphatidic acid ectonucleotide pyrophosphatase/phosphodiesterase 2 Mus musculus
4 Lysophosphatidic acid (LPA) is a potent bioactive lipid mediator that is produced mainly from lysophosphatidylcholine (LPC) via autotaxin (ATX) and is known to induce NP via LPA1 receptor signaling in mice. lysophosphatidic acid ectonucleotide pyrophosphatase/phosphodiesterase 2 Mus musculus